NCT06863636View on ClinicalTrials.gov

Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation

PHASE3RecruitingINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

September 9, 2024

Primary Completion Date

October 30, 2025

Study Completion Date

November 30, 2025

Conditions
Joint PainKnee OsteoarthritisHip Osteoarthritis
Interventions
DRUG

Celecoxib + Acetaminohen

One tablet of 200 mg / 200 mg a day

DRUG

Celecoxi + Acetaminophen

One tablet of 200 mg / 500 mg a day

DRUG

Celecoxib

One capsule of 200 mg a day

Trial Locations (1)

11000

RECRUITING

Laboratorio Silanes, S.A. de C.V., Mexico City

All Listed Sponsors
lead

Laboratorios Silanes S.A. de C.V.

INDUSTRY